Literature DB >> 25609138

Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin.

Patricia Kent1, Nicole Wilkinson, Marco Constante, Carine Fillebeen, Konstantinos Gkouvatsos, John Wagner, Marzell Buffler, Christiane Becker, Klaus Schümann, Manuela M Santos, Kostas Pantopoulos.   

Abstract

UNLABELLED: Functional inactivation of HFE or hemojuvelin (HJV) is causatively linked to adult or juvenile hereditary hemochromatosis, respectively. Systemic iron overload results from inadequate expression of hepcidin, the iron regulatory hormone. While HJV regulates hepcidin by amplifying bone morphogenetic protein (BMP) signaling, the role of HFE in the hepcidin pathway remains incompletely understood. We investigated the pathophysiological implications of combined Hfe and Hjv ablation in mice. Isogenic Hfe (-)/(-) and Hjv (-)/(-) mice were crossed to generate double Hfe (-)/(-) Hjv (-)/(-) progeny. Wild-type control and mutant mice of all genotypes were analyzed for serum, hepatic, and splenic iron content, expression of iron metabolism proteins, and expression of hepcidin and Smad signaling in the liver, in response to a standard or an iron-enriched diet. As expected, Hfe (-)/(-) and Hjv (-)/(-) mice developed relatively mild or severe iron overload, respectively, which corresponded to the degree of hepcidin inhibition. The double Hfe (-)/(-) Hjv (-)/(-) mice exhibited an indistinguishable phenotype to single Hjv (-)/(-) counterparts with regard to suppression of hepcidin, serum and hepatic iron overload, splenic iron deficiency, tissue iron metabolism, and Smad signaling, under both dietary regimens. We conclude that the hemochromatotic phenotype caused by disruption of Hjv is not further aggravated by combined Hfe/Hjv deficiency. Our results provide genetic evidence that Hfe and Hjv operate in the same pathway for the regulation of hepcidin expression and iron metabolism. KEY MESSAGES: Combined disruption of Hfe and Hjv phenocopies single Hjv deficiency. Single Hjv(-)/(-) and double Hfe(-)/(-)Hjv(-)/(-) mice exhibit comparable iron overload. Hfe and Hjv regulate hepcidin via the same pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25609138     DOI: 10.1007/s00109-015-1253-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  36 in total

1.  Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice.

Authors:  Emilio Ramos; Léon Kautz; Richard Rodriguez; Michael Hansen; Victoria Gabayan; Yelena Ginzburg; Marie-Paule Roth; Elizabeta Nemeth; Tomas Ganz
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

2.  BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice.

Authors:  Elena Corradini; Paul J Schmidt; Delphine Meynard; Cinzia Garuti; Giuliana Montosi; Shanzhuo Chen; Slobodan Vukicevic; Antonello Pietrangelo; Herbert Y Lin; Jodie L Babitt
Journal:  Gastroenterology       Date:  2010-08-01       Impact factor: 22.682

Review 3.  Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.

Authors:  Antonello Pietrangelo
Journal:  Gastroenterology       Date:  2010-06-11       Impact factor: 22.682

4.  Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin.

Authors:  Paul J Schmidt; Nancy C Andrews; Mark D Fleming
Journal:  Blood       Date:  2010-09-13       Impact factor: 22.113

5.  Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis.

Authors:  John D Ryan; Eleanor Ryan; Aurelie Fabre; Matthew W Lawless; John Crowe
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

6.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.

Authors:  Jodie L Babitt; Franklin W Huang; Diedra M Wrighting; Yin Xia; Yisrael Sidis; Tarek A Samad; Jason A Campagna; Raymond T Chung; Alan L Schneyer; Clifford J Woolf; Nancy C Andrews; Herbert Y Lin
Journal:  Nat Genet       Date:  2006-04-09       Impact factor: 38.330

7.  Iron absorption and distribution in TNF(DeltaARE/+) mice, a model of chronic inflammation.

Authors:  Klaus Schümann; Nadia Herbach; Christina Kerling; Markus Seifert; Carine Fillebeen; Isabella Prysch; Jens Reich; Günter Weiss; Kostas Pantopoulos
Journal:  J Trace Elem Med Biol       Date:  2009-11-17       Impact factor: 3.849

8.  Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.

Authors:  Daniel F Wallace; Lesa Summerville; Emily M Crampton; David M Frazer; Gregory J Anderson; V Nathan Subramaniam
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

9.  In situ proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 (Tfr2) do not interact.

Authors:  Gautam Rishi; Emily M Crampton; Daniel F Wallace; V Nathan Subramaniam
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

Review 10.  Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis.

Authors:  Amanda B Core; Susanna Canali; Jodie L Babitt
Journal:  Front Pharmacol       Date:  2014-05-13       Impact factor: 5.810

View more
  16 in total

1.  Blood and iron.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2015-05       Impact factor: 4.599

2.  Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway.

Authors:  Mastura Wahedi; Aaron M Wortham; Mark D Kleven; Ningning Zhao; Shall Jue; Caroline A Enns; An-Sheng Zhang
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

3.  A crosstalk between hepcidin and IRE/IRP pathways controls ferroportin expression and determines serum iron levels in mice.

Authors:  Edouard Charlebois; Carine Fillebeen; Angeliki Katsarou; Aleksandr Rabinovich; Kazimierz Wisniewski; Vivek Venkataramani; Bernhard Michalke; Anastasia Velentza; Kostas Pantopoulos
Journal:  Elife       Date:  2022-09-06       Impact factor: 8.713

4.  ALK3 undergoes ligand-independent homodimerization and BMP-induced heterodimerization with ALK2.

Authors:  Lisa Traeger; Inka Gallitz; Rohit Sekhri; Nicole Bäumer; Tanja Kuhlmann; Claudia Kemming; Michael Holtkamp; Jennifer-Christin Müller; Uwe Karst; Francois Canonne-Hergaux; Martina U Muckenthaler; Donald B Bloch; Andrea Olschewski; Thomas B Bartnikas; Andrea U Steinbicker
Journal:  Free Radic Biol Med       Date:  2018-09-15       Impact factor: 7.376

5.  Deficits of learning and memory in Hemojuvelin knockout mice.

Authors:  Jinglong Li; Peng Zhang; Hongju Liu; Wei Ren; Jinjing Song; Elizabeth Rao; Eiki Takahashi; Ying Zhou; Weidong Li; Xiaoping Chen
Journal:  J Vet Med Sci       Date:  2015-05-29       Impact factor: 1.267

Review 6.  Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.

Authors:  Jing Liu; Bingbing Sun; Huijun Yin; Sijin Liu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

7.  Minor variant of rs 16827043 in the iron regulator hemojuvelin gene (HJV) contributes to hypertension: The TAMRISK study.

Authors:  Seppo T Nikkari; Anni-Laura Visto; Kirsi M Määttä; Tarja A Kunnas
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

Review 8.  Regulation of Iron Homeostasis and Related Diseases.

Authors:  Yikun Li; Xiali Huang; Jingjing Wang; Ruiling Huang; Dan Wan
Journal:  Mediators Inflamm       Date:  2020-05-02       Impact factor: 4.711

Review 9.  Inherited Disorders of Iron Overload.

Authors:  Kostas Pantopoulos
Journal:  Front Nutr       Date:  2018-10-29

10.  MyD88 Adaptor Protein Is Required for Appropriate Hepcidin Induction in Response to Dietary Iron Overload in Mice.

Authors:  Antonio Layoun; Macha Samba-Mondonga; Gabriela Fragoso; Annie Calvé; Manuela M Santos
Journal:  Front Physiol       Date:  2018-03-05       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.